Pharmacology and Toxicology Research for Drug Development and Discovery
Envol Biomedical is a leading nonclinical laboratory offering pharmacology and toxicology capabilities focused on nonhuman primates.
Access to the largest population of readily available native and non-native nonhuman primates (old-world and new-world) in the continental U.S.
Dedicated to providing cost-effective studies with extremely fast turn-around time.
Dedicated to the on-time delivery of study samples and study reports (standard and specific study protocols).
AAALAC accredited, USDA and OLAW compliant.
Learn More
Why Choose Envol Biomedical?
Nonhuman primate preclinical research
Largest population available in the continental U.S.
On time delivery of study samples and study reports
AAALAC accredited, USDA and OLAW compliant
Our Capabilities
Envol Biomedical is a leading nonhuman primate research facility that builds on over 20 years of primate capabilities. Our strategy is to 1) create an exceptional team, 2) foster a successful culture, and 3) focus on our clients. Our team applies cutting-edge pharmacology and surgical models to facilitate drug development, primarily in the areas of gene targeting and biologics. We provide pharmacokinetics, pharmacodynamics, and toxicology research to help advance technologies with best-in-class capabilities. The best way to learn about our capabilities is to come visit the laboratory. We look forward to seeing you.We specialize in analyzing drug absorption, distribution, metabolism, and excretion to guide dosing strategies for safe and effective treatments.
Our in-depth understanding of how drugs interact with the body enables precise assessment of their effects, crucial for optimizing therapeutic outcomes.
With a focus on safety, we meticulously evaluate the potential harm of substances, ensuring they meet stringent regulatory standards.
News & Insights
May 14, 2025
Expert Insights: C. Edwin Garner on FDA’s Animal Testing Statements and the Real Impact on Drug Development
In the rapidly evolving world of drug development, industry leaders are carefully monitoring the recent...
May 8, 2025
Envol Biomedical Joins the LNP Alliance: Unlocking New Potential for Biopharma Innovation
Envol Biomedical is proud to announce its role as a founding member of the LNP Alliance,...
May 6, 2025
Envol Biomedical Heads to ASGCT 2025: Advancing Primate Research for the Future of Gene and Cell Therapy
The American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, taking placenext week from May 13th...Talk to an Expert About Our Research & Services
For inquiries about our research and services, don't hesitate to get in touch with our experts. Your journey to innovation starts here.